The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.
作者信息
Thachil Jecko, Longstaff Colin, Favaloro Emmanuel J, Lippi Giuseppe, Urano Tetsumei, Kim Paul Y
机构信息
Department of Haematology, Manchester University Hospitals, Manchester, UK.
Haemostasis Section, Biotherapeutics, National Institute for Biological Standards and Control, Potters Bar, UK.
出版信息
J Thromb Haemost. 2020 Sep;18(9):2408-2411. doi: 10.1111/jth.14956.
Abstract
摘要
相似文献
1
The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.COVID-19中准确D-二聚体报告的必要性：国际血栓与止血学会纤溶专业委员会的沟通
J Thromb Haemost. 2020 Sep;18(9):2408-2411. doi: 10.1111/jth.14956.
2
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
3
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.危重症 COVID-19 肺炎患者旋转血栓弹性描记术评估凝血功能。
J Thromb Thrombolysis. 2020 Aug;50(2):281-286. doi: 10.1007/s11239-020-02130-7.
4
Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.新型冠状病毒肺炎病毒感染患者静脉和动脉血栓栓塞事件的诊断
J Thromb Thrombolysis. 2020 Aug;50(2):302-304. doi: 10.1007/s11239-020-02163-y.
5
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.COVID-19 急性呼吸窘迫综合征患者的促凝模式。
J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.
6
Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).从纵向实验室检测推断 COVID-19 相关凝血障碍 (CAC) 的时间演变。
Elife. 2020 Aug 17;9:e59209. doi: 10.7554/eLife.59209.
7
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.评估 COVID-19 和细菌性肺炎患者 D-二聚体水平的变化：一项回顾性分析。
J Thromb Thrombolysis. 2020 Oct;50(3):548-557. doi: 10.1007/s11239-020-02171-y.
8
COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.新型冠状病毒肺炎凝血功能障碍与炎症：已知与未知
Anesth Analg. 2020 Nov;131(5):1323. doi: 10.1213/ANE.0000000000005215.
9
A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.一场完美风暴：COVID-19大流行期间维生素K拮抗剂超治疗性抗凝的根本原因分析
Thromb Res. 2020 Aug;192:73-74. doi: 10.1016/j.thromres.2020.05.024. Epub 2020 May 16.
10
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.新冠肺炎患者中性粒细胞与淋巴细胞比值和 D-二聚体的临床意义：中国苏州的一项回顾性研究。
Thromb Res. 2020 Aug;192:3-8. doi: 10.1016/j.thromres.2020.05.006. Epub 2020 May 6.
引用本文的文献
1
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID).三肽素治疗重症 COVID-19 患者的疗效和安全性：一项随机、安慰剂对照、双盲、多中心、II 期临床试验（ESsCOVID）的结果。
Eur J Med Res. 2024 Aug 13;29(1):418. doi: 10.1186/s40001-024-02008-x.
2
International Normalized Ratio Predicts Recurrence and Bleeding in Patients With Acute Venous Thromboembolism Who Undergo Direct Oral Anticoagulants.国际标准化比值预测直接口服抗凝剂治疗的急性静脉血栓栓塞症患者的复发和出血。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241246004. doi: 10.1177/10760296241246004.
3
Advances in D-dimer testing: progress in harmonization of clinical assays and innovative detection methods.D-二聚体检测的进展：临床检测方法的协调统一和创新检测方法的进展。
Anal Bioanal Chem. 2024 Jul;416(16):3737-3750. doi: 10.1007/s00216-024-05207-x. Epub 2024 Mar 20.
4
D-dimer diagnostics: can I use any D-dimer assay? Bridging the knowledge-to-action gap.D-二聚体诊断：我可以使用任何D-二聚体检测方法吗？弥合知识与行动之间的差距。
Res Pract Thromb Haemost. 2024 Feb 1;8(1):102335. doi: 10.1016/j.rpth.2024.102335. eCollection 2024 Jan.
5
A pipeline to further enhance quality, integrity and reusability of the NCCID clinical data.进一步提高 NCCID 临床数据质量、完整性和可重用性的流程。
Sci Data. 2023 Jul 27;10(1):493. doi: 10.1038/s41597-023-02340-7.
6
Laboratory Testing of Hemostasis in Pregnancy: A Brief Overview.妊娠期止血功能检测：简要概述。
Methods Mol Biol. 2023;2663:111-125. doi: 10.1007/978-1-0716-3175-1_7.
7
Harmonization of Hemostasis Testing Across a Large Laboratory Network: An Example from Australia.在大型实验室网络中实现止血检测的协调一致：来自澳大利亚的一个范例。
Methods Mol Biol. 2023;2663:71-91. doi: 10.1007/978-1-0716-3175-1_5.
8
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study.危重症新型冠状病毒肺炎患者的抗凝策略与安全性：一项法国回顾性多中心研究
Thromb J. 2023 Apr 18;21(1):42. doi: 10.1186/s12959-023-00491-6.
9
Fibrin monomers evaluation during hospitalization for COVID-19 is a predictive marker of in-hospital mortality.新冠病毒疾病住院期间纤维蛋白单体评估是院内死亡率的预测指标。
Front Cardiovasc Med. 2023 Mar 30;10:1001530. doi: 10.3389/fcvm.2023.1001530. eCollection 2023.
10
Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis.定量纤溶的检测方法：优缺点。国际血栓与止血学会科学和标准化委员会关于纤溶的通讯。
J Thromb Haemost. 2023 Apr;21(4):1043-1054. doi: 10.1016/j.jtha.2023.01.008. Epub 2023 Jan 14.
本文引用的文献
1
Uncertainties on the prognostic value of D-dimers in COVID-19 patients.新冠病毒肺炎患者中D-二聚体预后价值的不确定性
J Thromb Haemost. 2020 Aug;18(8):2066-2067. doi: 10.1111/jth.14876. Epub 2020 May 28.
2
Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels.新型冠状病毒肺炎患者急性肺栓塞的CT血管造影表现及其与D-二聚体水平的关系
Radiology. 2020 Sep;296(3):E189-E191. doi: 10.1148/radiol.2020201561. Epub 2020 Apr 23.
3
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands.新型冠状病毒肺炎相关血栓栓塞性并发症的诊断、预防和治疗：荷兰国家公共卫生研究所报告。
Radiology. 2020 Oct;297(1):E216-E222. doi: 10.1148/radiol.2020201629. Epub 2020 Apr 23.
4
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.入院时 D-二聚体水平预测 COVID-19 患者住院死亡率。
J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859.
5
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.COVID-19 急性呼吸窘迫综合征患者的促凝模式。
J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.
6
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
7
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
8
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
9
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
10
Harmonisation of D-dimer - A call for action.D-二聚体的标准化——行动呼吁。
Thromb Res. 2016 Jan;137:219-220. doi: 10.1016/j.thromres.2015.11.031. Epub 2015 Nov 22.
Zotero 插件